- Estimated deadline
- May 27, 2027
- Expected posting
- May 27, 2025
- Award size
- Not listed
- Total program funding
- Not listed
- Expected awards
- Not listed
- Cost sharing
- Not required
- Funding type
- Grant
- Category
- Health
Check this solicitation free
Grantee reads the full announcement and lists every required section, page limit, deadline, scoring criterion and compliance item. Takes about two minutes, no account needed.
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID), with partnering National Institutes of Health Institutes, Centers, and Offices, seeks to advance its mission through continued support for the Implementation and Evaluation of Databases to Examine AIDS Consortium. This research network integrates clinical, epidemiologic, genomic, and contextual real-world data through harmonized data standards and interoperable data systems to generate evidence, perform data-driven research, and advance implementation science. Regional Cohort Centers collaborate across scientific working groups to investigate research priorities and develop innovative analytic methods. The consortium will apply cutting-edge data science approaches and incorporate emerging artificial intelligence technologies through scalable tools, computational models, and workflows to support data sharing, re-use, and reproducibility. The consortium supports studies of HIV morbidity, mortality, comorbidities, and multidimensional risk factors for HIV. As a platform for implementation science, the consortium evaluates strategies to improve HIV prevention, treatment, and care, contributing to the goals of the U.S. Ending the HIV Epidemic initiative. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
Who can apply
- Other Native American tribal organizations
- For-profit organizations
- Nonprofits without 501(c)(3) status
- County governments
- Federally recognized tribal governments
- Private universities
- Small businesses
- Special district governments
- State governments
- City or township governments
- Public and Indian housing authorities
- Other (see eligibility)
- Public and state universities
- Nonprofits with 501(c)(3) status
- Independent school districts
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations. Note: This funding opportunity is specifically designed to support funded international collaborations between a domestic prime organization and foreign organizations. One or more International Project is required. This NOFO should not be used for projects in which the only international elements are foreign consultants, purchasing unique equipment or supplies from foreign vendors, foreign collaborations that do not involve NIH funding or any other foreign component that would not result in a foreign subaward.
Agency contact
National Institute of Allergy and Infectious Diseases (NIAID), Division of Acquired Immunodeficiency Syndrome (DAIDS)
Please contact via e-mail.
- Reads the full solicitation and lays out every required section
- Drafts each section with you, in your words
- Checks the draft against every requirement before you submit
How to write it
All guidesMore from NIH
All NIH funding- Closes todayRFA-HG-27-011
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
Deadline Oct 30, 2026(0d)Up to $1.3M
- Closes todayRFA-HG-27-013
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
Deadline Oct 30, 2026(0d)Up to $500K
- Closes todayRFA-HG-27-012
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
Deadline Oct 30, 2026(0d)Up to $2.3M
- Closes todayPAR-27-045
HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)
Deadline Oct 30, 2026(0d)
- Closes in 3 daysPAR-24-280
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Deadline Nov 2, 2026(3d)
- Closes in 3 daysPAR-24-279
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
Deadline Nov 2, 2026(3d)
Get new funding every Monday
New federal opportunities and upcoming deadlines for NIH and more, in one short email. Free, unsubscribe anytime.
Details from Grants.gov, last updated Oct 13, 2026. Deadlines and requirements can change: always confirm them in the official notice.